TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
Published: 07 May 2024
-
Views:
599 -
Likes:
7
-
Views:
599 -
Likes:
7
-
3m 43sPart 1 Introduction Martin Swaans, Sabine Bleiziffer, Vijay Kunadian, Marta Sitges
-
16m 1sPart 2 TAVI: Current Status and Valve Durability Marta Sitges
-
12m 18sPart 3 Data from the ACC 2024 Sabine Bleiziffer
Overview
In this on-demand version of the live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), faculty explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.
Leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University, UK) and Dr Marta Sitges (Hospital Clínic de Barcelona, ES), discuss valve design and durability, clinical data from the SMART trial presented at ACC 2024 and how we can provide greater access for women in TAVI.
Learning Objectives
- Recall TAVI SMART trial data and the implications on clinical practice
- Describe novel valve designs and the impact on long-term performance
- Develop an expert-led approach to improving equitable access to TAVI
Target Audience
- General Cardiologists
- Echocardiographers
- Physiologists
- Physicians referring patients for TAVI
- Interventional Cardiologists
- Cardiac Surgeons
More from this programme
Part 1
Introduction
1 session | |
Introduction | Watch now |
Part 2
TAVI: Current Status and Valve Durability
Part 3
Data from the ACC 2024
1 session | |
Data from the ACC 2024 | Watch now |
Part 4
Improving Access
1 session | |
Improving Access | Watch now |
Part 5
Panel Discussion and Audience Q&A
1 session | |
Panel Discussion and Audience Q&A | Watch now |
Faculty Biographies
Vijay Kunadian
Professor of Interventional Cardiology
Prof Vijay Kunadian is Personal Chair and Professor of Interventional Cardiology at Newcastle University.
Prof Kunadian completed all her cardiology training in the North East of England. She undertook an international academic fellowship in cardiology at the TIMI/PERFUSE Study group, Brigham and Women’s Hospital/Harvard Medical School, Boston MA.
Prof Kunadian has an international reputation in interventional cardiology and cardiovascular research, making her a sought-after and respected speaker at prominent national and international meetings. She has championed diversity in her specialty as a role model; only 5% of interventional cardiologist are female in the UK, <1% are clinical academics.
Comments